Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R B Gearry

Showing results (31-40 of 38) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 38 results.
Genes and Immunity|May 7, 2010
Evidence that glioma-associated oncogene homolog 1 is not a universal risk gene for inflammatory bowel disease in CaucasiansR W Bentley, I Cleynen, R B Gearry, et al.
International Journal of Clinical Practice|May 25, 2013
The low FODMAP diet improves gastrointestinal symptoms in patients with irritable bowel syndrome: a prospective studyR H de Roest, B R Dobbs, B A Chapman, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|April 9, 2008
Single nucleotide polymorphisms in human Paneth cell defensin A5 may confer susceptibility to inflammatory bowel disease in a New Zealand Caucasian populationL R Ferguson, B L Browning, C Huebner, et al.
Alimentary Pharmacology & Therapeutics|January 28, 2010
Dietary poorly absorbed, short-chain carbohydrates increase delivery of water and fermentable substrates to the proximal colonJ S Barrett, R B Gearry, J G Muir, et al.
Internal Medicine Journal|March 5, 2014
Perspectives of paediatric and adult gastroenterologists on transfer and transition care of adolescents with inflammatory bowel diseaseE K Wright, J Williams, J M Andrews, et al.
Alimentary Pharmacology & Therapeutics|December 21, 2016
Infliximab vs. adalimumab in Crohn's disease: results from 327 patients in an Australian and New Zealand observational cohort studyJ D Doecke, F Hartnell, P Bampton, et al.
Alimentary Pharmacology & Therapeutics|August 29, 2015
Efficacy of thiopurines and adalimumab in preventing Crohn's disease recurrence in high-risk patients - a POCER study analysisP De Cruz, M A Kamm, A L Hamilton, et al.
Journal of Medical Genetics|August 19, 2007
Gender-stratified analysis of DLG5 R30Q in 4707 patients with Crohn disease and 4973 controls from 12 Caucasian cohortsB L Browning, V Annese, M L Barclay, et al.
Pageof 4

Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
Genes and Immunity|May 7, 2010
Evidence that glioma-associated oncogene homolog 1 is not a universal risk gene for inflammatory bowel disease in CaucasiansR W Bentley, I Cleynen, R B Gearry, et al.
International Journal of Clinical Practice|May 25, 2013
The low FODMAP diet improves gastrointestinal symptoms in patients with irritable bowel syndrome: a prospective studyR H de Roest, B R Dobbs, B A Chapman, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|April 9, 2008
Single nucleotide polymorphisms in human Paneth cell defensin A5 may confer susceptibility to inflammatory bowel disease in a New Zealand Caucasian populationL R Ferguson, B L Browning, C Huebner, et al.
Alimentary Pharmacology & Therapeutics|January 28, 2010
Dietary poorly absorbed, short-chain carbohydrates increase delivery of water and fermentable substrates to the proximal colonJ S Barrett, R B Gearry, J G Muir, et al.
Internal Medicine Journal|March 5, 2014
Perspectives of paediatric and adult gastroenterologists on transfer and transition care of adolescents with inflammatory bowel diseaseE K Wright, J Williams, J M Andrews, et al.
Alimentary Pharmacology & Therapeutics|December 21, 2016
Infliximab vs. adalimumab in Crohn's disease: results from 327 patients in an Australian and New Zealand observational cohort studyJ D Doecke, F Hartnell, P Bampton, et al.
Alimentary Pharmacology & Therapeutics|August 29, 2015
Efficacy of thiopurines and adalimumab in preventing Crohn's disease recurrence in high-risk patients - a POCER study analysisP De Cruz, M A Kamm, A L Hamilton, et al.
Journal of Medical Genetics|August 19, 2007
Gender-stratified analysis of DLG5 R30Q in 4707 patients with Crohn disease and 4973 controls from 12 Caucasian cohortsB L Browning, V Annese, M L Barclay, et al.
Pageof 4